Key facts
- A-wave’s last known valuation is $8.1M (Feb 2026).
- It has raised $5.7M; the latest was Later Stage VC ($3.5M) in Feb 2026.
- Notable investors include Mitsubishi UFJ Capital, Global Brain, DEEPCORE, Osaka University Venture Capital, JP Life Next Fund — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for A-wave
- ·The full record, as it builds
Funding rounds
No funding rounds for A-wave are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About A-wave
Developer of monitoring devices designed to help heart failure patients. The company offers a remote medical treatment system that uses a wristwatch-type wearable device to detect cardiac murmurs, reduced activity, and peripheral colds, enabling healthcare professionals to detect early symptoms of heart failure in patients at home.
- Sector
- Healthcare
- HQ
- Osaka, Japan
- Founded
- 2020
- Website
- awave.co.jp/
- Ownership
- Privately Held (backing)
A-wave doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in A-wave shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on A-wave in its N-PORT filings yet. We sweep new filings monthly.